HAVCR2 and lung cancer: Furthermore, it has been documented that heightened Tim-3 levels are linked to the emergence of resistance against PD-1 blockade, evident in both lung cancer patient samples and lung cancer models, as well as samples taken from patients with head and neck cancer (222, 223).